Drug Type Small molecule drug |
Synonyms Picosulfate, Picosulphate, Sodium Picosulfate + [15] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (27 Aug 1979), |
Regulation- |
Molecular FormulaC18H15NNa2O8S2 |
InChIKeyGNCMLBKBMBXVMB-UHFFFAOYSA-N |
CAS Registry10040-45-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01612 | Sodium Picosulfate Hydrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Contrast agents | JP | 01 Jul 1992 | |
Intestinal preparation | JP | 27 Mar 1992 | |
Constipation | JP | 27 Aug 1979 | |
Constipation | JP | 27 Aug 1979 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastrointestinal Diseases | Phase 3 | FR | 01 Nov 2014 | |
Gastrointestinal Diseases | Phase 3 | DE | 01 Nov 2014 | |
Gastrointestinal Diseases | Phase 3 | NL | 01 Nov 2014 | |
Diffuse Large B-Cell Lymphoma | Phase 3 | JP | 01 Sep 2014 | |
Constipation - functional | Phase 3 | CN | 16 Sep 2011 | |
Pharmaceutical aids | Phase 3 | US | 01 May 2010 |
Phase 4 | - | 862 | Standard dosing | uqzyrkhxuc(jnbzctsmle) = lyuwwfslgj karrttmsyt (ggbublmezi ) | - | 01 Aug 2014 | |
Split dosing | uqzyrkhxuc(jnbzctsmle) = icnrswsunh karrttmsyt (ggbublmezi ) |